Prosecution Insights
Last updated: April 19, 2026

Entralta

23 pending office actions • 13 clients

Portfolio Summary

23
Total Pending OAs
4
Final Rejections
19
Non-Final OAs

Client Portfolio (13 clients)

Client (Assignee)Pending OAs
Tracklet Inc. 2
Cls Therapeutics Limited 2
Oculogenex Inc. 1
Meb Holdings LLC 1
Lokport Corp. 1
Liquid Biosciences, Inc. 1
Watershed Medical Inc. 1
Kb Pro, LLC 1
Innomed Technologies, Inc. 1
Medalynx, Inc. 1
Cedars-Sinai Medical Center 1
Dawako Medtech, S.L. 1
King'S College London 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19390429 Untitled Unknown BEISNER, WILLIAM H 1799 Non-Final OA
19388858 Untitled Unknown LOPEZLIRA, ASHLEY NICOLE 1799 Non-Final OA
19335476 Untitled Unknown FAUST, AMBER KATHLEEN 1643 Non-Final OA
19197886 MICRONEEDLE DEVICE FOR INTRAOCULAR INJECTIONS AND METHODS OF USING THE SAME Oculogenex Inc. TRINH, HONG-VAN N 3783 Final Rejection May 02, 2025
19037137 METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND COVID-19 Unknown JOHANSEN, PETER N. 1671 Non-Final OA Jan 25, 2025
18926059 REGULATION OF CELLS AND ORGANISMS Unknown FAUST, AMBER KATHLEEN 1643 Final Rejection Oct 24, 2024
18902315 REGULATION OF CELLS AND ORGANISMS Unknown BATES, KEENAN ALEXANDER 1631 Non-Final OA Sep 30, 2024
18589334 DEVICE AND SOFTWARE APPLICATION FOR DETECTING BLOOD ALCOHOL CONTENT Tracklet Inc. DOUGHERTY, SEAN PATRICK 3791 Non-Final OA Feb 27, 2024
18581367 HIGH EFFICIENCY PLANTER SYSTEM AND METHOD Meb Holdings LLC NGUYEN, SON T 3643 Non-Final OA Feb 19, 2024
18430615 SECURE CONTAINER AND METHOD OF OPERATION SAME Lokport Corp. HENSEL, BRENDAN A 1758 Non-Final OA Feb 01, 2024
18563348 IMMUNOMODULATION OF TUMOR MICROENVIRONMENT Cls Therapeutics Limited PRIEST, JESSICA MARIE 1642 Non-Final OA Nov 21, 2023
18380137 SYSTEMS AND METHODS FOR DETERMINING ATTRIBUTES OF BIOLOGICAL SAMPLES Liquid Biosciences, Inc. COTHRAN, BERNARD E 2188 Non-Final OA Oct 13, 2023
18285643 REGULATION OF CELLS AND ORGANISMS Unknown MARVICH, MARIA 1634 Non-Final OA Oct 04, 2023
18285645 FORMULATION AND METHOD FOR TREATMENT OF URINARY SYSTEM DISORDERS Watershed Medical Inc. CHANG, KYUNG SOOK 1613 Non-Final OA Oct 04, 2023
18273760 SYSTEM AND METHOD FOR USING A WEARABLE DEVICE WITH BIOFEEDBACK SENSORS TO MITIGATE DISEASE TRANSMISSION Tracklet Inc. HAILE, BENYAM 2688 Non-Final OA Jul 21, 2023
18349884 AIRWAY DEVICE Kb Pro, LLC PINDERSKI, JACQUELINE M 3785 Non-Final OA Jul 10, 2023
18251235 SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT CANCER Unknown HOLLAND, PAUL J 1656 Non-Final OA Apr 29, 2023
18306099 FORMULATIONS CONTAINING ERYTHRITOL AND COMBINATION SKIN THERAPIES Innomed Technologies, Inc. WELLES, COLMAN THOMAS 1612 Final Rejection Apr 24, 2023
18030498 SYSTEM AND METHODS FOR HARMONIZING AND ANALYZING MEDICAL DATA Medalynx, Inc. RUIZ, JOSHUA DAMIAN 3684 Non-Final OA Apr 05, 2023
18161781 NOVEL BLOOD CELL BIOMARKER FOR LATE ONSET ALZHEIMER'S DISEASE Cedars-Sinai Medical Center HALVORSON, MARK 1646 Non-Final OA Jan 30, 2023
17794928 WEARABLE ULTRASOUND APPARATUS Dawako Medtech, S.L. HUSSAINI, ATTIYA SAYYADA 3792 Non-Final OA Jul 22, 2022
17767859 ANTI-CANCER LEUCINE-RICH PEPTIDES AND USES THEREOF King'S College London DABKOWSKI, ERINNE R 1654 Non-Final OA Apr 08, 2022
17626616 TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNase) ACTIVITY Cls Therapeutics Limited WEN, SHARON X 1641 Final Rejection Jan 12, 2022

Managing Entralta's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month